Literature DB >> 12543626

Accuracy of fetal growth indicators as surrogate measures of steroid hormone levels during pregnancy.

Jennifer David Peck1, Barbara S Hulka, David A Savitz, Donna Baird, Charles Poole, Barbara E Richardson.   

Abstract

This study evaluates the use of fetal growth characteristics as surrogate measures for steroid hormone exposures during pregnancy. The validity of using birth weight, birth length, ponderal index, and placental weight as indicators of pregnancy hormone exposures was assessed using third-trimester serum samples from 568 pregnant women who participated in the Child Health and Development Studies, Berkeley, California (1959-1966). The magnitude of the associations between birth characteristics and hormone concentrations was assessed using geometric means, Pearson's correlations, and linear and logistic regression. Accuracy was evaluated using sensitivity, specificity, and receiver operating characteristic curve analyses. The strongest and most consistent association observed was between birth weight and estriol levels. Despite a positive correlation (r = 0.32) and strong associations with high estriol levels (odds ratio for highest compared with lowest birth weight quartile = 6.63, 95% confidence interval: 3.20, 12.5), the predictive performance of birth weight as a proxy for estriol levels was poor (area under the receiver operating characteristic curve = 0.66, 95% confidence interval: 0.61, 0.71). Likewise, all fetal growth measures revealed little discriminatory ability as indicators of estriol, estrone, estradiol, or progesterone levels. Thus, observed associations with these surrogate measures may not be a reflection of pregnancy hormone exposure and should be interpreted with caution.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12543626     DOI: 10.1093/aje/kwf183

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  20 in total

1.  Fetal growth and subsequent maternal risk of colorectal cancer.

Authors:  Casey Crump; Jan Sundquist; Weiva Sieh; Marilyn A Winkleby; Kristina Sundquist
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-06-02       Impact factor: 4.254

2.  Fetal growth and subsequent maternal risk of thyroid cancer.

Authors:  Casey Crump; Jan Sundquist; Weiva Sieh; Marilyn A Winkleby; Kristina Sundquist
Journal:  Int J Cancer       Date:  2015-10-05       Impact factor: 7.396

3.  Birth weight and other prenatal factors and risk of breast cancer in Asian-Americans.

Authors:  Anna H Wu; Roberta McKean-Cowdin; Chiu-Chen Tseng
Journal:  Breast Cancer Res Treat       Date:  2011-06-28       Impact factor: 4.872

Review 4.  Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature.

Authors:  Sarah Nechuta; Nigel Paneth; Ellen M Velie
Journal:  Cancer Causes Control       Date:  2010-03-12       Impact factor: 2.506

5.  A population-based case-control study of fetal growth, gestational age, and maternal breast cancer.

Authors:  Sarah Nechuta; Nigel Paneth; Dorothy R Pathak; Joseph Gardiner; Glenn Copeland; Ellen M Velie
Journal:  Am J Epidemiol       Date:  2010-09-21       Impact factor: 4.897

6.  Biological indicators of the in-utero environment and their association with birth weight for gestational age.

Authors:  N M Talge; C Holzman; P K Senagore; M Klebanoff; R Fisher
Journal:  J Dev Orig Health Dis       Date:  2011-10       Impact factor: 2.401

7.  Placental weight and risk of invasive epithelial ovarian cancer with an early age of onset.

Authors:  Sven Cnattingius; Sandra Eloranta; Hans-Olov Adami; Ove Axelsson; Paul W Dickman; Chung-cheng Hsieh; Lorelei A Mucci; Dimitrios Trichopoulos; Mats Lambe; Anna L V Johansson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-09       Impact factor: 4.254

8.  Gestational age and fetal growth in relation to maternal ovarian cancer risk in a Swedish cohort.

Authors:  Lorelei A Mucci; Paul W Dickman; Mats Lambe; Hans-Olov Adami; Dimitrios Trichopoulos; Tomas Riman; Chung-Cheng Hsieh; Sven Cnattingius
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-09       Impact factor: 4.254

Review 9.  Defining normal and abnormal fetal growth: promises and challenges.

Authors:  Jun Zhang; Mario Merialdi; Lawrence D Platt; Michael S Kramer
Journal:  Am J Obstet Gynecol       Date:  2010-01-13       Impact factor: 8.661

10.  Associations of Maternal Exposure to Dichlorodiphenyltrichloroethane and Pyrethroids With Birth Outcomes Among Participants in the Venda Health Examination of Mothers, Babies and Their Environment Residing in an Area Sprayed for Malaria Control.

Authors:  Jonathan Chevrier; Stephen Rauch; Madelein Crause; Muvhulawa Obida; Fraser Gaspar; Riana Bornman; Brenda Eskenazi
Journal:  Am J Epidemiol       Date:  2019-01-01       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.